Sano D, Tokuhisa M, Takahashi H, Hatano T, et al. Real-world Therapeutic Outcomes of the Pembrolizumab Regimen as First-line Therapy for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck: A Single-center Retrospective Cohort Study in Japan. Anticancer Res 2022;42:4477-4484.
PMID: 36039457